Glucose-Lowering Overtreatment

The observed overtreatment prevalence was consistent with prior studies but definitions vary widely. The study framed overtreatment as glucose-lowering medication use where harms may outweigh benefits. The primary study outcome classified patients as potentially overtreated if they had two or more overlapping glucose-lowering medications or at least one insulin dispensing within 90 days after the index A1C test. The abstract also described sulfonylurea dispensing as part of the overtreatment outcome definition.